Treatment of Pediatric Hypertension With Altace Trial
Hypertension

About this trial
This is an interventional treatment trial for Hypertension focused on measuring ACE inhibitor, high blood pressure, pediatric
Eligibility Criteria
Inclusion criteria: Males or females age 6 to 16 years. All female subjects ≥ 8 years of age must have a negative urine pregnancy test and must use an acceptable method of contraception, including abstinence, a barrier method (diaphragm or condom), Depo-Provera, or an oral contraceptive, for the duration of the study. Weight ≥ 20 kg. Parents/guardians must be able to demonstrate their ability to use the home blood pressure device to monitor blood pressure. Sitting systolic blood pressure or sitting diastolic blood pressure ≥ the 95th percentile for age, gender and height; or diabetes mellitus or chronic renal insufficiency (as evidenced by GFR 40-70 mL/min/1.73 m2) and a sitting systolic blood pressure or sitting diastolic blood pressure ≥ the 90th percentile for age, gender, and height. Exclusion criteria: Severe hypertension documented by (1) Sitting systolic blood pressure or sitting diastolic blood pressure more than 20 mmHg above the 95th percentile for age, gender, and height without antihypertensive therapy, (2) Sitting systolic blood pressure or sitting diastolic blood pressure more than 12 mmHg above the 95th percentile for age, gender, and height while receiving active therapy, or (3) hypertensive encephalopathy within the previous 5 months. Currently receiving more than one antihypertensive medication including: ACE inhibitors, angiotensin receptor inhibitors, beta blockers, calcium channel blockers, diuretics. Receiving lithium, potassium supplements, monoamine oxidase inhibitors, or major tranquilizers (Note: Stimulant medications for behavioral disorders, corticosteroids, and non-steroidal anti-inflammatory agents for chronic pain management are permitted during the trial provided the subject's dosage is anticipated to remain unchanged throughout the duration of the study.) A history of cardiomyopathy, clinically significant structural heart disease or atrioventricular conduction disturbance, sick sinus syndrome, atrial flutter, atrial fibrillation, clinically significant bradycardia or an accessory bypass tract, or clinical symptoms of congestive heart failure.
Sites / Locations
- University of Alabama at Birmingham
- Sante Los Angeles
- Neufeld Medical Group
- UCLA Medical Center
- Medical College of Georgia
- Kapiolani Medical Center for Women and Children
- Nephrology and Hypertension Consultants
- University of Louisville
- Tulane University Health Sciences Center
- University of Maryland
- Children's Hospital of Michigan
- Univ of Missouri, Children's Mercy Hospital and Clinics
- St. Louis Children's Hospital
- Montefiore Medical Center c/o BRANY
- North Shore Univ Hospital c/o BRANY
- Children's Hospital Medical Center
- University Hospitals of Cleveland
- Cleveland Clinic Foundation
- PCTI at Columbus Children's Hospital
- Oregon Health and Science University
- Hershey Medical Center
- The Children's Hospital of Philadelphia
- Thomas Jefferson University Hospital
- The Children's Hospital of Pittsburgh
- Le Bonheur Children's Hospital - Univ of Tennessee
- Vanderbilt University Medical Center
- Texas Children's Hospital
- University of Texas Medical Center
- University of Virginia
- University of Wisconsin